Showing results (21-30 of 541) with videos related to
Sort By:
Pageof 55
The Annals of Pharmacotherapy|October 31, 2000
Mild cognitive impairment: emerging therapeuticsJ J Sramek, A E Veroff, N R CutlerExpert Opinion on Investigational Drugs|April 3, 2001
The status of ongoing trials for mild cognitive impairmentJ J Sramek, A E Veroff, N R CutlerProgress in Neuro-Psychopharmacology & Biological Psychiatry|May 1, 1994
A phase II multicenter dose-finding, efficacy and safety trial of ipsapirone in outpatients with generalized anxiety disorderN R Cutler, J M Hesselink, J J SramekClinical Therapeutics|May 1, 1997
Efficacy and safety of two dosing regimens of buspirone in the treatment of outpatients with persistent anxietyJ J Sramek, E J Frackiewicz, N R CutlerThe Annals of Pharmacotherapy|May 20, 1999
Cholinesterase inhibitors: a therapeutic strategy for Alzheimer diseaseW J Krall, J J Sramek, N R CutlerExpert Opinion on Investigational Drugs|April 3, 2001
Beta-amyloid therapies in Alzheimer's diseaseS Jhee, T Shiovitz, A W Crawford, et al.Life Sciences|April 21, 1999
NXX-066 in patients with Alzheimer's disease: a bridging studyJ J Sramek, J Hourani, S S Jhee, et al.Journal of Clinical Psychopharmacology|February 1, 1995
Efficacy trial of the 5-HT2 antagonist MDL 11,939 in patients with generalized anxiety disorderJ J Sramek, R E Robinson, A Suri, et al.European Journal of Clinical Pharmacology|January 1, 1985
Salicylate protein binding in serum from young and elderly subjects as measured by diafiltrationL J Lesko, P K Narang, L Yeager, et al.Clinical Pharmacokinetics|May 1, 2001
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative reviewS S Jhee, T Shiovitz, A W Crawford, et al.Pageof 55